XTalks

AUGUST 17, 2020

protein-based biologics) and vaccine treatments. protein-based biologics) : are those which bind to specific components (i.e. A growing area in the immunotherapy space is the development of biological modulators, which are genetically engineered proteins that target specific components of the immune system.

Protein 98

Protein Engineer Immune Response In-Vivo 98

XTalks

DECEMBER 5, 2023

Augtyro, a tyrosine kinase inhibitor (TKI), is available as oral capsules, each containing 40 mg of repotrectinib. As its active ingredient, repotrectinib inhibits the proto-oncogene tyrosine-protein kinase ROS1 and the tropomyosin receptor tyrosine kinases (TRKs) TRKA, TRKB and TRKC.

Protein 115

Protein FDA Approval Medicine Trials 115

XTalks

AUGUST 26, 2020

Researchers studied the proteins that act as chemical signals and conducted experiments to see how those signals were affecting the macrophages. They found a protein called Rspondin3, which is released at high levels during inflammatory injury. This protein plays a crucial role in macrophage programming.

Bacteria 105

Bacteria Immune Response Protein Medicine 105

XTalks

JANUARY 3, 2024

In individuals affected by ATTR, which includes both hereditary and wild-type (non-hereditary) variants, the TTR protein forms fibrils that accumulate in various tissues. These tissues comprise peripheral nerves, the heart, gastrointestinal system, eyes, kidneys, central nervous system, thyroid and bone marrow.

FDA Approval 105

FDA Approval Protein RNA Clinical Trials 105

XTalks

JUNE 16, 2021

The company’s candidate recombinant nanoparticle protein-based COVID-19 vaccine, NVX-CoV2373, is being evaluated in the PREVENT-19 (the PRE-fusion protein subunit Vaccine Efficacy Novavax Trial COVID-19) Phase III trial, which has close to 30,000 participants across 119 states in the US and Mexico.

Vaccination 98

Vaccination Vaccine Protein Trials 98

XTalks

JUNE 28, 2023

DMD is caused by the absence of dystrophin, a protein that helps maintain the integrity of muscle cells. Elevidys’ approval was based on data from a randomized trial that showed the therapy increased expression of the Elevidys micro-dystrophin protein, which was used as a surrogate endpoint, in DMD patients aged four to five years of age.

Gene Therapy 98

Gene Therapy Gene Protein FDA Approval 98

XTalks

MAY 4, 2021

Related: 2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences. To develop CRISPRoff, the researchers generated a single “dead” Cas9 fusion protein capable of mediating DNA methylation and repressive histone modifications, but devoid of any DNA cleavage function. pyogenes dCas9.

DNA 98

DNA Gene Gene Silencing Genome 98

XTalks

DECEMBER 1, 2021

While researchers are still working out the epidemiological, clinical and molecular details of Omicron, so far, it is known that the variant is laden with up to 50 mutations, 30 or so of which are just in its outer spike (S) protein. The company said as a result, Omicron’s spike mutations do not impact the accuracy of its tests.

Gene 105

Gene Genome Genomics Genetics 105

XTalks

OCTOBER 24, 2024

While research is still ongoing, studies suggest that low-calorie diets, the Mediterranean diet and protein restriction may reduce inflammation. Nutrient-rich foods containing omega-3 fatty acids, prebiotics and curcumin could also help improve immune function and alleviate symptoms.

Research 105

Research Dermatology Clinical Trials Clinical Trials 105

XTalks

MAY 24, 2022

Now, Gilead has replaced the material of the container vial with aluminosilicate glass, proving it to be a good material for storage and compatibility. “We Lenacapavir is designed to act as an inhibitor of the HIV capsid protein, and it inhibits the virus at distinct stages (early and late) of its life cycle.

Drugs 98

Drugs Clinical Trials Clinical Trials Trials 98

XTalks

AUGUST 25, 2021

Of course, these factors were also aspects of their life that influenced the life expectancy, but researchers adjusted for this and took it into account in their analysis. Walnuts contain a number of essential nutrients, including protein, fiber, and magnesium and have a decent amount of omega 3 fatty acids.

Nurses 97

Nurses Research Containment Protein 97

XTalks

JANUARY 14, 2021

variant has several other mutations in the spike protein apart from the N501Y mutation (which is also in the spike protein). It has a notable deletion at positions 69 and 70 which may cause conformational changes in the protein. This variant contains the same N501Y mutation as B.1.1.7 In addition to B.1.1.7, 1.135 or 501.V2

Genetics 98

Genetics Genome Genomics Protein 98

XTalks

AUGUST 6, 2020

Epidiolex is the only FDA-approved formulation that contains CBD derived from the cannabis plant. CBD is the most abundant non-psychoactive cannabinoid compound found in the cannabis plant, making up about 40 percent of the plant’s extract, which contains over 100 different cannabinoid compounds.

FDA Approval 64

FDA Approval Protein Containment Genetic Disease 64

XTalks

MAY 4, 2023

Celiac disease is an autoimmune disorder that is triggered by the consumption of gluten, a protein found in barley, wheat and rye. When a person with celiac disease eats something that contains gluten, their immune system attacks their small intestine, damaging the lining and interfering with the absorption of nutrients from food.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Immune Response 98

XTalks

JANUARY 28, 2022

Kimmtrak is a bispecific protein that contains a soluble T cell receptor fused to an anti-CD3 immune-effector function. The median treatment time is about 23 weeks (or 5.3 months), so the average cost per patient will be approximately $400,000.

FDA Approval 98

FDA Approval Development Licensing Licensing 98

XTalks

NOVEMBER 23, 2020

Developed by researchers at the University of Oxford, the COVID vaccine is an adenovirus vector-based vaccine derived from chimpanzees that contains a genetically engineered virus that causes the common cold in chimpanzees, along with the spike protein of the SARS-CoV-2 coronavirus.

Vaccination 97

Vaccination Vaccine Clinical Trials Clinical Trials 97

XTalks

NOVEMBER 6, 2020

Graves explained the gene therapy platform delivers plasmid DNA that enables a patient’s own cells to produce therapeutic proteins that work to clear harmful virus particles from healthy tissues.

Clinical Trials 75

Clinical Trials Clinical Trials Vaccination Vaccine 75

XTalks

MAY 1, 2023

Qalsody contains tofersen, an antisense oligonucleotide that specifically targets the mRNA made from mutated SODI genes to prevent the formation of toxic SOD1 proteins. To date, over 200 mutations in the SOD1 gene have been associated with the development of ALS. How Does Qalsody Work?

FDA Approval 89

FDA Approval Gene Genetics Protein 89

XTalks

SEPTEMBER 8, 2020

The genetic material contains SARS-CoV-2 spike protein. The vaccine uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus that causes infections in chimpanzees. The Phase 3 trial is being implemented as part of Operation Warp Speed.

Manufacturing 83

Manufacturing Vaccination Vaccine Allergies 83

XTalks

FEBRUARY 27, 2023

The lysosomal storage disorder is caused by mutations in the MAN2B1 gene, which codes for lysosomal alpha-mannosidase, an enzyme that degrades glycoproteins (proteins attached to sugar residues). A lack of this enzyme results in a toxic build-up of mannose-containing sugars in the cells of the body, including the central nervous system (CNS).

FDA Approval 52

FDA Approval Life Science Containment Genetics 52

XTalks

JANUARY 31, 2022

The third group will contain unimmunized individuals who will get three doses of the omicron shot. However, the company noted that cell-mediated immunity was not significantly impacted by omicron, as 85 percent of epitopes in the spike protein have been observed to be recognized by CD8+ T cells.

Vaccination 98

Vaccination Vaccine Trials Antibody 98

The Pharma Data

DECEMBER 13, 2020

13, 2020 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. About SELLAS Life Sciences Group, Inc. SELLAS’ lead product candidate, galinpepimut-S (GPS), is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms Tumor 1 (WT1) protein, which is present in an array of tumor types.

Life Science 52

Life Science Sales Licensing Licensing 52

The Pharma Data

OCTOBER 26, 2020

The agreement covers the gene therapy program targeting OTOF (OTOF-GT), the gene encoding the otoferlin protein. Novasep provides cost-effective and sustainable manufacturing solutions for the life sciences industries. This press release contains certain forward-looking statements concerning Sensorion and its business.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

XTalks

DECEMBER 14, 2021

The quadrivalent influenza vaccine candidate, mRNA-1010, is targeted against hemagglutinin (HA) proteins from four seasonal influenza viruses, which include two influenza A subtypes, H1N1 and H3N2, and two influenza B subtypes, Yamagata and Victoria. These strains of the virus were recommended by the World Health Organization (WHO).

Vaccination 98

Vaccination Vaccine Immune Response Antibody 98

XTalks

OCTOBER 26, 2023

The Flu versus COVID-19: Virology and Vaccines SARS-CoV-2 versus Influenza Virology Viruses contain genetic material that can either be RNA or DNA. This means COVID-19 can quickly produce viral proteins once inside the host cell, which may make its replication cycle faster than influenza. remains the dominant variant.

Vaccination 105

Vaccination Vaccine RNA Manufacturing 105

XTalks

AUGUST 7, 2023

It then activates enzymes known as neutral serine proteases, which are responsible for protein degradation. ’s berdazimer gel, containing 10.3 Once applied, cantharidin is absorbed by the lipid layers of the epidermal cell membranes. Another noteworthy contender is Novan Inc.’s percent of the active ingredient SB206.

FDA Approval 98

FDA Approval Dermatology Trials Clinical Trials 98

The Pharma Data

NOVEMBER 23, 2020

Under the partnership, Evotec will support Rappta’s programme of developing small molecule activators of the enzyme Protein Phosphatase 2A (“PP2A”), which downregulates multiple oncogenic signalling pathways responsible for driving cancer progression. Rappta has a strong scientific, management and commercial team.

Development 40

Development Protein Regulation Drugs 40

The Pharma Data

DECEMBER 8, 2020

They contain proteins, nucleic acids and metabolites, which carry information from secreting to receiving cells. Exosomes carry information of secreting to receiving cells utilising proteins, nucleic acids and metabolites. . EVOTEC AND SARTORIUS FORM CONSORTIUM TO SUPPORT CUREXSYS’ € 8.2 M SEED FINANCING ROUND.

Manufacturing 52

Manufacturing Containment Life Science Production 52

XTalks

APRIL 26, 2021

The vaccine is protein-based and contains an adjuvant (MM), a component that helps generate a stronger immune response, that was developed by Novavax. Oxford researchers developed the R21/MM malaria vaccine in collaboration with the Serum Institute of India and biotech company Novavax. Malaria Vaccine Phase II Trial.

Vaccination 105

Vaccination Vaccine Immune Response Trials 105

XTalks

OCTOBER 8, 2024

A gene contains instructions within our DNA. To activate these instructions, cells create a copy called messenger RNA (mRNA), which exits the nucleus and directs the cell’s machinery to produce a specific protein. However, microRNAs can bind to this mRNA, preventing it from functioning.

Regulation 52

Regulation Genetics Scientist RNA 52

XTalks

DECEMBER 13, 2023

Bolstered by world-class R&D capabilities, a highly productive scientific platform and an established management team, Alpine is dedicated to crafting first- or best-in-class multifunctional immunotherapies through distinctive protein engineering technologies, all aimed at enhancing the quality of life for patients.

Genetics 111

Genetics Vaccination Vaccine DNA 111

XTalks

SEPTEMBER 15, 2020

Specifically, the vaccine contains human recombinant glutamate decarboxylase 65 (GAD65) protein conjugated to aluminum hydroxide (GAD-alum). The vaccine triggers an immune response against pro-inflammatory processes resulting from autoimmune attack of the pancreas – the inflammation helps to destroy the insulin-producing ?-islet

Vaccination 103

Vaccination Vaccine Insulin Trials 103

XTalks

MAY 4, 2021

Related: 2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences. To develop CRISPRoff, the researchers generated a single “dead” Cas9 fusion protein capable of mediating DNA methylation and repressive histone modifications, but devoid of any DNA cleavage function. pyogenes dCas9.

DNA 52

DNA Gene Gene Silencing Genome 52

XTalks

MAY 15, 2023

Protalix BioTherapeutics focuses on the production, development and commercialization of recombinant therapeutic proteins. Elfabrio is available as a clear and colorless solution in single-dose vials, containing 20 mg/10 mL (2 mg/mL) of pegunigalsidase alfa-iwxj. The administration of Elfabrio is performed by a healthcare professional.

FDA Approval 98

FDA Approval Gene Genetics Clinical Trials 98

The Pharma Data

JANUARY 18, 2021

Life Sciences Leader, Ernst & Young), Andrew Cheng (President and CEO, Akero Therapeutics), and Marshall Fordyce (President and CEO, Vera Therapeutics ). About Abingworth Abingworth is a leading transatlantic life sciences investment firm. “Dr. .” For more info, please visit abingworth.com.

Development 40

Development Life Science Protein Clinical Development 40

The Pharma Data

APRIL 22, 2023

The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to mutations that could make the vaccine less effective over time. The Huck Institutes of Life Sciences and the College of Agricultural Sciences provided support for studies performed at Penn State.

Vaccination 40

Vaccination Vaccine Protein Antibody 40

XTalks

SEPTEMBER 30, 2024

Gold Nanocrystals — Insights into Nanomedicine Central to Clene’s efforts is CNM-Au8 , an oral suspension containing gold nanocrystals. CNM-Au8 works by improving the health of mitochondria — the energy producers in our cells — while also reducing harmful oxidative stress and lowering levels of misfolded proteins.

Research 59

Research Clinical Trials Clinical Trials Drugs 59